Untargeted Plasma Metabolomics and Gut Microbiome Profiling Provide Novel Insights into the Regulation of Platelet Reactivity in Healthy Individuals

Abstract Background Considerable variation exists in platelet reactivity to stimulation among healthy individuals. Various metabolites and metabolic pathways influence platelet reactivity, but a comprehensive overview of these associations is missing. The gut microbiome has a strong influence on the plasma metabolome. Here, we investigated the association of platelet reactivity with results of untargeted plasma metabolomics and gut microbiome profiling. Methods We used data from a cohort of 534 healthy adult Dutch volunteers (the 500 Functional Genomics study). Platelet activation and reactivity were measured by the expression of the alpha-granule protein P-selectin and the binding of fibrinogen to the activated integrin αIIbβ3, both in unstimulated blood and after ex vivo stimulation with platelet agonists. Plasma metabolome was measured using an untargeted metabolic profiling approach by quadrupole time-of-flight mass spectrometry. Gut microbiome data were measured by shotgun metagenomic sequencing from stool samples. Results Untargeted metabolomics yielded 1,979 metabolites, of which 422 were identified to play a role in a human metabolic pathway. Overall, 92/422 (21.8%) metabolites were significantly associated with at least one readout of platelet reactivity. The majority of associations involved lipids, especially members of eicosanoids, including prostaglandins and leukotrienes. Dietary-derived polyphenols were also found to inhibit platelet reactivity. Validation of metabolic pathways with functional microbial profiles revealed two overlapping metabolic pathways (“alanine, aspartate, and glutamate metabolism” and “arginine biosynthesis”) that were associated with platelet reactivity. Conclusion This comprehensive overview is an resource for understanding the regulation of platelet reactivity by the plasma metabolome and the possible contribution of the gut microbiota.

[1]  L. Zagrean,et al.  Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review , 2021, Journal of clinical medicine.

[2]  Guangji Wang,et al.  Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host–Microbe Interplay , 2020, Trends in Endocrinology & Metabolism.

[3]  C. Takacs-Vesbach,et al.  Isotopic and genetic methods reveal the role of the gut microbiome in mammalian host essential amino acid metabolism , 2020, Proceedings of the Royal Society B.

[4]  Oliver Fiehn,et al.  A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors , 2020, Cell.

[5]  John C. Earls,et al.  Blood metabolome predicts gut microbiome α-diversity in humans , 2019, Nature Biotechnology.

[6]  P. Meikle,et al.  Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability , 2019, Thrombosis and Haemostasis.

[7]  Krista A. Zanetti,et al.  Pre-Analytical Factors that Affect Metabolite Stability in Human Urine, Plasma, and Serum: A Review , 2019, Metabolites.

[8]  H. Osborn,et al.  Synthetic Flavonoids as Novel Modulators of Platelet Function and Thrombosis , 2019, International journal of molecular sciences.

[9]  S. Narumiya,et al.  Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice , 2019, Thrombosis and Haemostasis.

[10]  M. Grenegård,et al.  Individual variations in platelet reactivity towards ADP, epinephrine, collagen and nitric oxide, and the association to arterial function in young, healthy adults. , 2019, Thrombosis research.

[11]  S. Smeekens,et al.  The Inter-Relationship of Platelets with Interleukin-1β-Mediated Inflammation in Humans , 2018, Thrombosis and Haemostasis.

[12]  Karsten Zengler,et al.  GABA Modulating Bacteria of the Human Gut Microbiota , 2018, Nature Microbiology.

[13]  R. Sturmey,et al.  Glucose metabolism and metabolic flexibility in blood platelets , 2018, Journal of thrombosis and haemostasis : JTH.

[14]  A. M. James,et al.  Ischemic preconditioning protects against cardiac ischemia reperfusion injury without affecting succinate accumulation or oxidation. , 2018, Journal of molecular and cellular cardiology.

[15]  David S. Wishart,et al.  MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..

[16]  Andrew D. Johnson,et al.  ADP Platelet Hyperreactivity Predicts Cardiovascular Disease in the FHS (Framingham Heart Study) , 2018, Journal of the American Heart Association.

[17]  M. Holinstat,et al.  The expansive role of oxylipins on platelet biology , 2017, Journal of Molecular Medicine.

[18]  M. During,et al.  Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis , 2017, Platelets.

[19]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[20]  C. Huttenhower,et al.  Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity , 2016, Cell.

[21]  Richard A. Notebaart,et al.  Host and Environmental Factors Influencing Individual Human Cytokine Responses , 2016, Cell.

[22]  S. Hazen,et al.  Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.

[23]  Zhang Yanyan,et al.  Acetic acid in aged vinegar affects molecular targets for thrombus disease management. , 2015, Food & function.

[24]  A. Franco,et al.  Platelets at the interface of thrombosis, inflammation, and cancer. , 2015, Blood.

[25]  Kyongbum Lee,et al.  Prediction and quantification of bioactive microbiota metabolites in the mouse gut , 2014, Nature Communications.

[26]  S. Bhattacharya,et al.  The sex specific effects of extraneous testosterone on ADP induced platelet aggregation in platelet‐rich plasma from male and female subjects , 2014, International journal of laboratory hematology.

[27]  C. Miller,et al.  Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results , 2014, British journal of haematology.

[28]  Y. Chiang,et al.  Characteristics of endogenous γ-aminobutyric acid (GABA) in human platelets: functional studies of a novel collagen glycoprotein VI inhibitor , 2014, Journal of Molecular Medicine.

[29]  F. Sinigaglia,et al.  Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation , 2012, Steroids.

[30]  Peter Donnelly,et al.  Human metabolic profiles are stably controlled by genetic and environmental variation , 2011, Molecular systems biology.

[31]  B. Olde,et al.  Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3‐kinase‐β signaling , 2011, Journal of thrombosis and haemostasis : JTH.

[32]  Andrew J. Johnson,et al.  The role of prostanoid receptors in mediating the effects of PGE2 on human platelet function , 2010, Platelets.

[33]  Andrew D. Johnson,et al.  Genome-wide meta-analyses identifies 7 loci associated with platelet aggregation in response to agonists , 2010, Nature genetics.

[34]  Chris I. Jones,et al.  A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. , 2009, Blood.

[35]  Adam M. Feist,et al.  A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information , 2007, Molecular systems biology.

[36]  T. Keränen,et al.  GABA and glutamate transporters are expressed in human platelets. , 2005, Brain research. Molecular brain research.

[37]  M. Mcmurdo,et al.  Comparison of Compositions and Metabolic Activities of Fecal Microbiotas in Young Adults and in Antibiotic-Treated and Non-Antibiotic-Treated Elderly Subjects , 2004, Applied and Environmental Microbiology.

[38]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[39]  W. Erl,et al.  The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. , 2004, Blood.

[40]  D. Vaughan,et al.  Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function , 2004, Hypertension.

[41]  T. Saldeen,et al.  Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. , 2003, The American journal of clinical nutrition.

[42]  Makoto Murakami,et al.  Phospholipase A2 enzymes. , 2002, Prostaglandins & other lipid mediators.

[43]  J. Freedman,et al.  Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. , 2001, The Journal of nutrition.

[44]  M. Mauri,et al.  Plasma and Platelet Amino Acid Concentrations in Patients Affected by Major Depression and under Fluvoxamine Treatment , 1998, Neuropsychobiology.

[45]  Y. Hannun,et al.  15-Hydroxyeicosatetraenoic acid-mediated potentiation of thrombin-induced platelet functions occurs via enhanced production of phosphoinositide-derived second messengers--sn-1,2-diacylglycerol and inositol-1,4,5-trisphosphate. , 1992, Blood.

[46]  M. Mayer,et al.  Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  G. L. Le Breton,et al.  Prostaglandin H2 directly lowers human platelet cAMP levels. , 1983, Thrombosis research.